Insider Buying: Dean Tozer Acquires 38,700 Shares of Cytomedix Stock (CMXI)
Cytomedix (NASDAQ:CMXI) Insider Dean Tozer acquired 38,700 shares of the stock on the open market in a transaction that occurred on Friday, August 22nd. The shares were purchased at an average cost of $0.38 per share, for a total transaction of $14,706.00. Following the transaction, the insider now directly owns 86,700 shares of the company’s stock, valued at approximately $32,946. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.
Cytomedix (NASDAQ:CMXI) traded up 1.32% during mid-day trading on Monday, hitting $0.385. The stock had a trading volume of 307,815 shares. Cytomedix has a 52-week low of $0.33 and a 52-week high of $0.68. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.47. The company’s market cap is $47.9 million.
Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.
Receive News & Ratings for Cytomedix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytomedix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.